Abstract:
Objective To monitor the antimicrobial resistance of Escherichia coli separated from the main specimen types and different ward areas timely, so as to provide basis for the rational use of antimicrobial agents and control of infection.
Methods The antimicrobial resistance of non-repeated Escherichia coli strains separated during January 1, 2017 to December 31 were analyzed separately by WHONET 5.6 software. These strains were isolated from different specimen and from different wards .
Results The resistance rates of Escherichia coli isolated from sputum, blood and urine to imipenem were 1.63%, 0.46% and 0.30%, respectively. The resistance rates of levofloxacin to quinolones were 45.65%, 41.94% and 56.70%, respectively. The resistance rates of Escherichia coli isolated from ICU, Nephrology and pediatrics wards to imipenem, quinolones and levofloxacin were 2.15%, 0.00%, 0.00% and 52.69%, 50.00% and 21.84%, respectively.
Conclusion The resistance rates of Escherichia coli isolated from different specimens and different ward areas in our hospital were significantly different. Timely understanding the resistance of the main pathogens from different sources can reduce treatment failure.
Key words:
Different wards,
Different specimens,
Escherichia coli,
Drug resistance rate
Shuping Zhao, Meijie Jiang, Xia Chen. Drug resistance analysis of Escherichia coli isolated from different specimens in 2017[J]. Chinese Journal of Clinical Laboratory Management(Electronic Edition), 2019, 07(04): 226-229.